Department of Chemical Engineering Renamed to Reflect Expanding Focus

Content

The Department of Chemical Engineering at the University of Massachusetts Amherst has officially been renamed the Department of Chemical and Biomolecular Engineering (CBE). This change reflects the department's expanded focus and expertise in biologically-related work, including biomaterials, pharmaceuticals, biofuels, biomanufacturing, and bioprocess engineering.

While the department’s name has been updated, all existing degrees, majors, concentrations, and certificates will remain unchanged. The curriculum for both undergraduate and graduate programs will not be affected, although course designations in the SPIRE system may be updated to align with the new department name.

This strategic move aims to better communicate the department's research and instructional activities to prospective students, faculty, collaborators and partners, emphasizing its alignment with contemporary practices in the field.

As the biotech sector in Massachusetts continues to expand, the updated name positions the department to strengthen its connections with the biomolecular, biological, and health sciences sectors, as well as the biotechnology and pharmaceutical industries. This alignment with the needs of industry not only enhances the department's reputation but also ensures that its graduates are highly sought after in the job market.

Ultimately, this evolution of the department reflects a commitment to staying at the forefront of research, education and industry needs—equipping students with the skills and knowledge necessary to drive innovation and make a meaningful impact on the world. As the field of chemical and biomolecular engineering continues to evolve, so will the opportunities for discovery and advancement, making this an exciting time to be part of this dynamic and influential discipline.

As Department Head Dimitrios Maroudas reflected: “We are delighted to have chosen a new department name that better reflects who we are and what we do. This will have an impact on our student enrollment, strengthen our connections with the biotech and pharmaceutical industry, and more effectively communicate our research and teaching mission.”